Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-28

Clinical Trial Update: Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fludarabine and total-body irradiation as conditioning before donor stem cell transplantation for metastatic kidney cancer tha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fludarabine (Fludarabine)
  • Total Body Irradiation

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Kidney Cancer | Phase 2 | Status: TERMINATED